Peripheral glucocorticoid resistance in the light of recent knowledge of their actions

Endocrine Regulations

Volumn 32, Issue 1, 1998, Pages 51-61

  Tesfaye, H ^a   Hampl, R ^a   Starka L ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Glucocorticoids; Molecular mechanism; Resistance; Review

Indexed keywords

EID: 0007576776     PISSN: 12100668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. ADCOCK IM, BROWN CR, GELDER CM, SHIRASAKI H, PETERS MJ, BARNES PJ: Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 268 (Cell Physiol 37), C331-C338, 1995a
2. ADCOCK IM, LANE SJ, BROWN CR, LEE TH, BARNES PJ: Abnormal glucocorticoid receptor-activator protein-1 interaction in steroid resistant asthma. J Exp Med 182, 1951-1958, 1995b
3. ALAMO C, FERRANDIZ B, LOPEZ-MUNOZ F, ALGUACIL LF: Influence of butibufen on enzyme activity and lysosomal stabilization ex vivo: a comparative study with hydrocortisone and acetylsalicylic acid. Methods Find Exp Clin Pharmacol 17, 303-310, 1995
4. ALVAREZ J, SURS W, LEUNG DYM, IKLÉ D, GELFAND EW, SZEFLER SJ: Steroid-resistant asthma: Immunologic and pharmacologic features. J Allergy Clin Immunol 89, 714-721, 1992
5. ARANEO B, DAYNES R: Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology 136, 393-401, 1995
6. BARNES PJ, ADCOCK I: Anti-inflammatory actions of steroids: molecular mechanisms. TIPS Rev 14, 436-441, 1993
7. BEATO M: Gene regulation by steroid hormones. Cell 56, 335-344, 1989
8. BELL R, LILLQUIST A, MCCAFFREY R: Glucocorticoid receptors in leukemia cells: an appraisal. Leuk Res 8, 1919-1928, 1984
9. BERGHORN KA, KNAPP LT, HOFFMAN GE, SHERMAN TG: Induction of glucocorticoid receptor expression in hypothalamic magnocellular vasopressin neurons during hypoosmolality. Endocrinology 136, 804-808, 1995
10. BOUMPAS DT, PALIOGIANNI F, ANASTASSIOU ED, BALOW JE: Glucocorticoid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol 9, 413-423, 1991
11. BRANDON DD, ALMAN KR, TRAINER PJ, KENDALL JW, LORIAUX DL: Intracellular inhibitor of glucocorticoid receptor binding (abst.) 76th Annual Meeting of the Endocrine Society, Anaheim CA, Bethesda MD 1994, The Endocrine Society
12. BRÖNNEGARD M, WERNER S, GUSTAFSSON JA: Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. J Clin Invest 78, 1270-1278, 1986
13. BRÖNNEGARD M, CARLSTEDT-DUKE J: The genetic basis of glucocorticoid resistance. Trends in Endocrinol Metab 6, 160-164, 1995
14. BROWN TR: Androgen receptor dysfunction in human androgen insensitivity. Trends in Endocrinol Metab 6, 170-175, 1995
15. COHEN JJ: In: Anti-inflammatory steroid action. Basic and clinical aspects. Eds. RP Schleimer, HN Claman, AL Oronsky, pp. 111-131, Academic Press, San Diego 1989
16. CHROUSOS GP, CASTRO M, LEUNG DYM, WEBSTER E, KINO T, BAMBERGER C, ELLIOT S, STRATAKIS C, KARL M: Molecular mechanism of glucocorticoid resistance/hypersensitivity. Am J Respir Crit Care Med 154, S39-S44, 1966
17. CHROUSOS GP, GOLD PW: The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 267, 1244-1252, 1992
18. CHROUSOS GP, VINGERHOEDS ACM, LORIAUX DL, LIPSETT MB: Primary cortisol resistance: a family study. J Clin Endocrinol Metab 56, 1243-1245, 1983
19. CORRIGAN CJ, BROWN PH, BARNESS NC, TSAI JJ, KAY AB: Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 144, 1016-1025, 1991
20. CORRIGAN CJ, HACZKU A, GEMOU-ENGESAETH V, DOL S, KIKUCHI Y, TAKATSU K, DURHAM SR, KAY AB: CD4 T-lymphocyte action in asthma is accompanied by increased serum concentration of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 147, 540-547, 1993
21. CORVOL P, FUNDER J: The enigma of pseudoaldosteronism. J Clin Endocrinol Metab 79, 25-26, 1994
22. DERIJK RH, PETRIDES J, DEUSTER P, GOLD PW, STERNBERG EM: Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J Clin Endocrinol Metab 81, 228-235, 1996
23. DIDONATO JA, SAATCIOGLU F, KARIN M: Molecular mechanism of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 154, S11-S15, 1996
24. GOULDING NJ, GUYRE PM: Regulation of inflammation by lipocortin I. Immunol Today 13, 295-297
25. GOULDING NJ, GUYRE PM: Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 5, 108-113, 1993
26. GRIFFING TG: Dinosaurus and steroids. J Clin Endocrinol Metab 77, 1450-1451, 1993
27. HACZKU A, ALEXANDER A, BROWN P, ASSOUPI B, LI B, KAY AB, CORRIGAN C: The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: Comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 93, 510-519, 1994
28. HAMPL R, LAPÇÍK O, SULCOVA M, STARKA L, KALVACHOVA B, DVORAKOVA M, NȨMCOVA D, HOZA J: The effect of long-term glucocorticoid therapy on glucocorticoid receptor content and on steroid response to ACTH. J Steroid Biochem Molec Biol 48, 81-87, 1994
29. HEWISON M, RUT A, KRISTJANSSON K, WALKER RE, DILLON MJ, HUGHES MR, O'RIORDAN JLH: Tissue resistance to 1,25-dihydroxy-vitamin D without a mutation of vitamin D receptor gene. Clin Endocrinol 39, 663-670, 1993
30. HILL MR, SZEFLER SJ, BALL BD, BARTOSZEK M, BRENNER AM: Monitoring glucocorticoid therapy: a pharmacokinetics approach. Clin Pharmacol Ther 48, 390-398, 1990
31. IIDA S, GOMI M, MORIWAKI K, ITOH Y, HIROBE, MATSUZAWA Y, KATAGIRI S, YONEZAWA T, TARUI S: Primary cortisol resistance accompanied by a reduction in glucocorticoid receptors in two members of the same family. J Clin Endocrinol Metab 60, 967-971, 1985
32. KALIMI M, SHAFAGOJ Y, LORIA R, PADGETT D, REGELSON W: Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Molec Cell Biochem 131, 99-104, 1994
33. KAM JC, SZEFLER SJ, SURS W, SHER ER, LEUNG DYM: Combination IL-2 and 1L-4 reduces glucocorticoid receptor-binding affinity and T-cell response to glucocorticoids. J Immunol 151, 3460-3466, 1993
34. KAMADA AK, LEUNG DYM, GLEASON MC, HILL MR, SZEFLER FJ: High-dose systemic glucocorticoid therapy in the treatment of severe asthma: A case of resistance and patterns of response. J Allergy Clin Immunol 90, 685-687, 1992
35. KAMADA AK, SPAHN JD, SURS W, BROWN E, LEUNG DYM, SZEFLER SJ:Coexistence of glucocorticoid receptor and pharmacokinetics abnormalities: Factors that contribute to a poor response to treatment with glucocorticoids in children with asthma. J Pediatr 124, 984-986, 1994
36. KARL M, LAMBERTS SWJ, DETERA-WADLEIGH SD, ENCIO IJ, STRATAKIS CA, HURLEY DM, ACCILI D, CHROUSOS GP: Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 76, 683-689, 1993
37. LAMBERTS SWJ, POLDERMANS D, ZWEENS M, DE JONG FH: Familial cortisol resistance: Differential diagnostic and therapeutic aspects. J Clin Endocrinol Metab 63, 1328-1333, 1986
38. LAMBERTS SWJ, KOPER JW, BIEMOND P, DEN HOLDER FH, DE JONG FH: Familial and iatrogenic cortisol receptor resistance. Cancer Res 49 (Suppl 8), 2217-2219, 1989
39. LAMBERTS SWJ, KOPER JW, BIEMOND P, DEN HOLDER FH, DE JONG FH: Cortisol receptor resistance. The variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab 74, 313-321, 1992
40. LANGFORD CA: Chronic immunesuppressive for systemic vasculitis. Curr Opin Rheumatol 9, 41-47, 1997
41. MALCHOFF CD, JAVIER EC, MALCHOFF DM, MARTIN T, ROGOL A, BRANDON D, LORIAUX DL, REARDON GE: Primary cortisol resistance presenting as isosexual precocity. J Clin Endocrinol Metab 70, 503-507, 1990
42. MALCHOFF CD, MALCHOFF DM: Glucocorticoid resistance in humans. Trends in Endocrinol Metab 6, 89-95, 1995
43. MOSER R, GROSCURTH P, CARBALLIDS JM, BRUIJNZEEL PLB, BLAZER K, HEUSSER CH, FEHR J: Interleukin-4 induced tissue eosinophilia in mice: Correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophile. J Lab Clin Med 122, 567-575, 1993
44. MUNCK A, GUYRE PM, HOLBROOK NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev 5, 25-44, 1984
45. MUNCK A, MENDELL DB, SMITH LI, ORTÍ E: Glucocorticoid receptors and actions. Am J Respir Dis 141, S2-S10, 1990
46. MURPHY LM: Growth factor and steroid hormone action in endometrial cancer. J Steroid Biochem Molec Biol 48, 419-423, 1994
47. NARAY-FEJES-TÖTH A: Glucocorticoid action. In: Endocrinology, 3rd Edition, ed. LJ DeGroot, pp. 1647-1648, W.B. Saunders Co., Philadelphia 1995
48. NEWTON R, KUITERT LM, SLATER DM, ADCOCK IM, BARNES PJ: Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60, 67-78, 1997
49. NISHIZUKA Y: Studies and perspectives of protein kinase C Science Wash DC 233, 305-312, 1986
50. NORBIATO G, BEVILACQUA M, VAGO T, BALDI G, CHEBAT E, BERTORA P, MORONI M, GALLI M, OLDENBURG N: Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74, 608-613, 1992
51. PFEILSCHIFTER J, EBERHARDT W, HUMMEL R, KUNZ D, MUHL H, NITSCH D, PLUSS C, WALKER G: Therapeutic strategies for the inhibition of inducible nitric oxide synthase - potential for a new class of antiinflammatory agents. Cell Biol Int 20, 51-58, 1997
52. SATO A, SHEPPARD KE, FULLERTON MJ, SVIRIDOV DD, FUNDER JW: Glucocorticoid receptor expression is down-regulated by LP(a) lipoprotein in vascular smooth muscle cells. Endocrinology 136, 3707-3713, 1995
53. SCHLEIMER RP: An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 45, 3-7, 1993
54. SHER ER, LEUNG DYM, SURS W, KAM JC, TIEG G, KAMADA AK, SZEFLER SJ: Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93, 33-39, 1994
55. TRUSS M, BEATO M: Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev 14, 459-479, 1993
56. VINGERHOEDS ACM, THIJSSEN JHH, SCHWARZ F: Spontaneous hypercortisolism without Cushing's syndrome. J Clin Endocrinol Metab 43, 1128-1133, 1976
57. WERNER S, THORÉN M, GUSTAFSSON JA, BRÖNNEGARD M: Glucocorticoid receptor abnormalities in fibroblasts from patients with idiopathic resistance to dexamethasone diagnosed when evaluated for adrenocortical disorders. J Clin Endocrinol Metab 75, 1005-1009, 1992